Welcome to
On Feet Nation
Digital_Zone Online
Steven Online
Robert Online
Lura Online
basitkhatr6666 Online
Mitul Hasan Online
Posted by Digital_Zone on August 11, 2024 at 1:17pm 0 Comments 0 Likes
Posted by Lura on August 11, 2024 at 1:16pm 0 Comments 0 Likes
Emcure Pharmaceuticals Ltd (EPL) on Friday said it will launch its generic version of anti-COVID-19 pill Molnupiravir in a week in India. The company plans to launch Molnupiravir under the brand name 'Lizuvira' in the Indian market, EPL said in a statement.
"As the need for such a drug is imminent in the face of emerging challenges in COVID-19 treatment, EPL will endeavour to deliver Lizuvira (Molnupiravir) in a week's time. A toll-free helpline will be dedicated to help the doctors and patients access the product," it added. The Drug Controller General of India (DCGI) earlier this week approved Molnupiravir for restricted use in emergency situation (EUA) in India.
Read more at https://www.moneycontrol.com/news/coronavirus/emcure-pharmaceutical...
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation